Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview

被引：0
作者：
Roberta Gualtierotti
Marco Parisi
Francesca Ingegnoli
机构：
[1] ASST Pini-CTO,Lupus Clinic, Department of Rheumatology and Medical Sciences
[2] University of Milan,Department of Clinical Sciences and Community Health
[3] ASST Santi Paolo e Carlo,Department of Orthopaedic Surgery and Traumatology, San Paolo Hospital
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Biological; DMARD; Inflammatory rheumatic diseases; Perioperative management; Rheumatoid arthritis; Systemic lupus erythematosus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patients with inflammatory rheumatic diseases often need orthopaedic surgery due to joint involvement. Total hip replacement and total knee replacement are frequent surgical procedures in these patients. Due to the complexity of the inflammatory rheumatic diseases, the perioperative management of these patients must envisage a multidisciplinary approach. The frequent association with extraarticular comorbidities must be considered when evaluating perioperative risk of the patient and should guide the clinician in the decision-making process. However, guidelines of different medical societies may vary and are sometimes contradictory. Orthopaedics should collaborate with rheumatologists, anaesthesiologists and, when needed, cardiologists and haematologists with the common aim of minimising perioperative risk in patients with inflammatory rheumatic diseases. The aim of this review is to provide the reader with simple practical recommendations regarding perioperative management of drugs such as disease-modifying anti-rheumatic drugs, corticosteroids, non-steroidal anti-inflammatory drugs and tools for a risk stratification for cardiovascular and thromboembolic risk based on current evidence for patients with inflammatory rheumatic diseases.
引用
收藏
页码：439 / 456
页数：17
相关论文
共 622 条
[1]  
Gabriel SE(2009)Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases Arthritis Res Ther. 11 229-2300
[2]  
Michaud K(2002)Predictors of infection in rheumatoid arthritis Arthritis Rheum 46 2294-791
[3]  
Doran MF(2011)High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis Ann Rheum Dis 70 785-124
[4]  
Crowson CS(2017)Understanding cardiovascular risk in rheumatoid arthritis: still a long way to go Atherosclerosis. 256 123-346
[5]  
Pond GR(1999)Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus Arthritis Rheum 42 338-315
[6]  
O’Fallon WM(2014)Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk Expert Rev Clin Immunol. 10 307-874
[7]  
Gabriel SE(2014)Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991–2005 J Rheumatol. 41 867-220
[8]  
Au K(2003)Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessment Arthritis Rheum 49 216-341
[9]  
Reed G(2006)Orthopaedic surgery of the lower limbs in 49,802 rheumatoid arthritis patients: results from the Swedish National Inpatient Registry during 1987 to 2001 Ann Rheum Dis 65 335-7
[10]  
Curtis JR(2016)Reduction in orthopaedic surgery in patients with rheumatoid arthritis: a Norwegian register-based study Scand J Rheumatol. 45 1-1302
12345678910